Aerosol composition of a salt of ipratropium and a salt of albuterol
Patent 5603918 Issued on February 18, 1997. Estimated Expiration Date: 
June 9, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 9, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3219533 3322625 3551558 3644353 Methods for the treatment of nasal hypersecretion Method and apparatus for administering dehydrated liposomes by inhalation Patent #: 4895719 InventorAssigneeApplicationNo. 489201 filed on 06/09/1995US Classes:424/46, Powder or dust containing424/45, Organic pressurized fluid514/929VASODILATORExaminersPrimary: Lovering, Richard D.Attorney, Agent or FirmInternational ClassesA61K 009/12C09K 003/30 AbstractThe present invention is concerned with an aerosol formulation which contains an effective amount of a pharmaceutically acceptable salt of ipratropium and an effective amount of a pharmaceutically acceptable salt of albuterol in combination with an effective amount of soya lecithin as a suspending agent and a propellant. | |
